Drugs susceptibility profile (EC₅₀ values and Fold-change) to the antileishmanials in all polyene resistant lines of <i>Leishmania</i> spp. by Edubiel A. Alpizar-Sosa (13848145)

“…<p>Mean EC₅₀ values (μM) ± Standard Deviation (SD). …”

Comparison of semi-quantitative and quantitative assessments of CD3+ and CD8+ lymphocytes in association with overall survival. by Gerik W. Tushoski-Alemán (17951809)

Reduced GTPase activity of BipA_N128D. by Eunsil Choi (8271039)

Factors associated with stunting in healthy children aged 5 years and less living in Bangui (RCA) by Pascale Vonaesch (149522)

“…Most importantly, we identified being overweight [weight-for-height z-score (WHZ) > 2 SD; aOR: 3.21; 95% CI: 1.50; 6.90 of overweight compared to normal weight] as also being significantly associated with stunting. …”

Expression of cytokines by CD3+ infiltration in PDAC. by Gerik W. Tushoski-Alemán (17951809)

Expression of cytokines by CD8+ infiltration in PDAC. by Gerik W. Tushoski-Alemán (17951809)

Double immunofluorescence of Ext1 and vimentin in human cancer and immunostaining of αSMA, CD163, and CD8α in human colon cancer and pancreatic cancer. by Ayumi Niwa (6256790)

Quantification of intratumoral CD3+ and CD8+ lymphocytes. by Gerik W. Tushoski-Alemán (17951809)

Lipolytic treatment decreased cellular neutral lipids and increased extracellular fatty acids and glycerol. by Caroline Louis (332423)

“…<p>At day 11, differentiated rat adipocytes, which were previously contaminated with PCBs, were incubated with a lipolytic medium supplemented with 1 µM isoproterenol. We renewed the lipolytic medium every 3 hours for 12 hours. …”

Immunostaining of HS, Ext1, and vimentin in MC38 S.C. colon tumor. by Ayumi Niwa (6256790)

Immunostaining of HS, Ext1, and vimentin in Pan02 S.C. pancreatic tumor. by Ayumi Niwa (6256790)

Loss of <i>Nf1</i> increases sleep fragmentation and decreases sleep depth. by Elizabeth B. Brown (4582978)

“…<b>A</b>. There is a significant effect of genotype on sleep duration (two-way ANOVA: F_2,172 = 80.70, <i>P</i><0.0001). …”

Muscle quality, but not muscle thickness, is decreased in different age groups of active older women by Pedro Lopez (4530202)

Biologic activity of LY5 in sarcoma cell lines. by Peter Y. Yu (4281448)

ILK and talin mediate DZ-50 action on prostate cancer cell death and migration. by Patrick J. Hensley (518001)

“…On the left, DU-145 cells in which talin has been silence (shTalin) or overexpressed (Talin+), exhibit significant reduction or marked overexpression of talin protein levels respectively, relative to parental DU-145 cells. Panel B, DZ-50 treatment leads to a significant decrease in prostate cancer cell viability in a time-dependent fashion. …”

Scatterplot and line plot of predicted response for the 25^th, 50^th and 75th quantile for MCS in nonseminomas cases, on time between diagnosis and compilation... by Aleksandar Jovanovski (11529711)

Scatterplot and line plot of predicted response for the 25^th, 50^th and 75th quantile for PCS in nonseminomas cases, on time between diagnosis and compilation... by Aleksandar Jovanovski (11529711)

The key mechanical parameters of sprint as a function of speed. by Patrícia Dias Pantoja (5824004)

Potent 5‑Cyano-6-phenyl-pyrimidin-Based Derivatives Targeting DCN1–UBE2M Interaction by Wenjuan Zhou (115285)

“…After finding a novel inhibitor <b>DC-1</b> with IC₅₀ = 1.2 μM, we performed a series of chemical optimizations, which finally led to the discovery of a potent thiazole containing 5-cyano-6-phenylpyrimidin-based inhibitor <b>DC-2</b> (IC₅₀ = 15 nM). …”

Identification of a Novel Protein Phosphatase 2A Activator, PPA24, as a Potential Therapeutic for FOLFOX-Resistant Colorectal Cancer by Hannah Johnson (1342596)

“…<b>PPA24</b> (<b>19a</b>) was identified as the most cytotoxic compound with IC₅₀ values in the range of 2.36–6.75 μM in CRC and FOLFOX-resistant CRC cell lines. …”